Drug Formulation Differences: US vs. UK – What’s Really Going On?

 

Drug Formulation Differences: US vs. UK – What’s Really Going On?

 

 

In recent years, public figures like the Food Babe have shone a light on the additives in foods and how companies often use different formulations in different countries. This sparked a curiosity in me about whether the same thing happens in the pharmaceutical world. Spoiler alert: It does.

Esomeprazole (Nexium) – A US vs. UK Comparison Let's take a look at Nexium, a medication used to treat acid reflux. Though it’s widely prescribed, the formulations differ significantly between countries.

 

US Version (Capsule): Contains esomeprazole magnesium, gelatin, titanium dioxide, and color additives such as FD&C Yellow No. 6.

UK Version (Tablet): Contains esomeprazole magnesium but without some of the synthetic dyes found in the US formulation.

 

While the active ingredient remains the same, the non-medicinal ingredients differ. You might ask, "Why do we need synthetic dyes in our medications?" Well, we don’t! These dyes are used for branding and appearance, but in many cases, they can be linked to adverse reactions, including allergies. So why is the UK getting a ‘cleaner’ version of the same drug?

Why Is This Happening? Pharmaceutical companies often adjust formulations to meet the regulations of the country they are selling to. While some countries have stricter rules on certain additives, the US allows many ingredients that are banned elsewhere. In the case of food, this is well-documented, but it’s time we look deeper into drugs. We don’t need to reinvent the wheel here—the safer formulations are already being made.

 

Call to Action: Join Me on This Journey Just like the Food Babe is making waves in the food industry, I want to bring attention to this issue in pharmaceuticals. The industry shouldn’t be cutting corners with unnecessary and potentially harmful ingredients when cleaner alternatives already exist.

 

Join me as I continue to research and expose the differences in drug formulations worldwide. Let’s push for a safer and cleaner pharmaceutical industry. You can call me the “Drug Babe”—I’m ready to take on this challenge!

Sources:

1.       Nexium 40 mg gastro-resistant tablets - Summary of Product Characteristics (SmPC) - print friendly - (emc) (medicines.org.uk)

2.       AstraZeneca Medications (astrazeneca-us.com)